Our Story
Glycomir, a visionary spinout of Biomir, a highly focused and research-driven company committed to enhancing the quality of life. Rooted in Biomir’s ethos, Glycomir emerges as a beacon of innovation in the MedTech realm.
Our mission echoes Biomir’s dedication, acting as a dynamic platform that synergises cutting-edge research with expertise and strategic partnerships to revolutionise the discovery, development, and commercialisation of groundbreaking MedTech products. At Glycomir, we navigate the intersection of technology and healthcare, paving the way for transformative solutions that prioritise well-being. Join us on this journey to make a lasting impact on the world of medical technology.
Aims, Vision & Goals
"At Glycomir, we envision a future where healthcare is transformed through pioneering MedTech solutions. Building on the foundation laid by our parent company, Biomir, we aspire to be at the forefront of innovation, pushing the boundaries of what is possible in medical technology. Our vision is to create a world where cutting-edge advancements seamlessly integrate into the fabric of healthcare, enhancing diagnostics, treatment, and patient outcomes. With a relentless commitment to excellence, research-driven methodologies, and strategic collaborations, Glycomir aims to be a global leader, catalysing positive change and setting new standards in the MedTech industry. Together, we strive to redefine the landscape of healthcare, making it more accessible, efficient, and impactful for individuals and communities around the globe."
Market Landscape
The global advanced wound care market is experiencing significant growth propelled by several factors. Evidence-based treatments are gaining traction, addressing wound care needs more effectively. Additionally, the surge in chronic diseases, notably diabetes, has elevated the demand for advanced wound care solutions. The applications of catheter fixation, encompassing IV lines, arterial lines, chemotherapy ports, and PEG lines, contribute substantially to this expansion. Notably, GLYCOMIR has emerged as a response to this escalating demand, providing effective wound care solutions. Its role becomes particularly pivotal during times of natural disasters and conflicts, where access to efficient wound care becomes crucial for addressing medical needs.